Virginia Senkomago1, Janet Royalty2, Jacqueline W Miller2, Lee E Buenconsejo-Lum3, Vicki B Benard2, Mona Saraiya2. 1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: vsenkomago@cdc.gov. 2. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States. 3. Department of Family Medicine and Community Health, Pacific Regional Cancer Programs, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, United States.
Abstract
BACKGROUND: Cervical cancer incidence in the US-Affiliated Pacific Islands (USAPIs) is double that of the US mainland. American Samoa, Commonwealth of Northern Mariana Islands (CNMI), Guam and the Republic of Palau receive funding from the Centers for Disease Control (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to implement cervical cancer screening to low-income, uninsured or under insured women. The USAPI grantees report data on screening and follow-up activities to the CDC. MATERIALS AND METHODS: We examined cervical cancer screening and follow-up data from the NBCCEDP programs in the four USAPIs from 2007 to 2015. We summarized screening done by Papanicolaou (Pap) and oncogenic human papillomavirus (HPV) tests, follow-up and diagnostic tests provided, and histology results observed. RESULTS: A total of 22,249 Pap tests were conducted in 14,206 women in the four USAPIs programs from 2007-2015. The overall percentages of abnormal Pap results (low-grade squamous intraepithelial lesions or worse) was 2.4% for first program screens and 1.8% for subsequent program screens. Histology results showed a high proportion of cervical intraepithelial neoplasia grade 2 or worse (57%) among women with precancers and cancers. Roughly one-third (32%) of Pap test results warranting follow-up had no data recorded on diagnostic tests or follow-up done. CONCLUSION: This is the first report of cervical cancer screening and outcomes of women served in the USAPI through the NBCCEDP with similar results for abnormal Pap tests, but higher proportion of precancers and cancers, when compared to national NBCCEDP data. The USAPI face significant challenges in implementing cervical cancer screening, particularly in providing and recording data on diagnostic tests and follow-up. The screening programs in the USAPI should further examine specific barriers to follow-up of women with abnormal Pap results and possible solutions to address them. Published by Elsevier Ltd.
BACKGROUND:Cervical cancer incidence in the US-Affiliated Pacific Islands (USAPIs) is double that of the US mainland. American Samoa, Commonwealth of Northern Mariana Islands (CNMI), Guam and the Republic of Palau receive funding from the Centers for Disease Control (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to implement cervical cancer screening to low-income, uninsured or under insured women. The USAPI grantees report data on screening and follow-up activities to the CDC. MATERIALS AND METHODS: We examined cervical cancer screening and follow-up data from the NBCCEDP programs in the four USAPIs from 2007 to 2015. We summarized screening done by Papanicolaou (Pap) and oncogenic human papillomavirus (HPV) tests, follow-up and diagnostic tests provided, and histology results observed. RESULTS: A total of 22,249 Pap tests were conducted in 14,206 women in the four USAPIs programs from 2007-2015. The overall percentages of abnormal Pap results (low-grade squamous intraepithelial lesions or worse) was 2.4% for first program screens and 1.8% for subsequent program screens. Histology results showed a high proportion of cervical intraepithelial neoplasia grade 2 or worse (57%) among women with precancers and cancers. Roughly one-third (32%) of Pap test results warranting follow-up had no data recorded on diagnostic tests or follow-up done. CONCLUSION: This is the first report of cervical cancer screening and outcomes of women served in the USAPI through the NBCCEDP with similar results for abnormal Pap tests, but higher proportion of precancers and cancers, when compared to national NBCCEDP data. The USAPI face significant challenges in implementing cervical cancer screening, particularly in providing and recording data on diagnostic tests and follow-up. The screening programs in the USAPI should further examine specific barriers to follow-up of women with abnormal Pap results and possible solutions to address them. Published by Elsevier Ltd.
Entities:
Keywords:
Cervical cancer; NBCCEDP; Screening; US territories; US-Affiliated Pacific Islands
Authors: L Stewart Massad; Mark H Einstein; Warner K Huh; Hormuzd A Katki; Walter K Kinney; Mark Schiffman; Diane Solomon; Nicolas Wentzensen; Herschel W Lawson Journal: Obstet Gynecol Date: 2013-04 Impact factor: 7.661
Authors: Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young Journal: JAMA Date: 2002-04-24 Impact factor: 56.272
Authors: Christie R Eheman; Steven Leadbetter; Vicki B Benard; A Blythe Ryerson; Janet E Royalty; Donald Blackman; Lori A Pollack; Paula Willey Adams; Fran Babcock Journal: Cancer Date: 2014-08-15 Impact factor: 6.860
Authors: Nancy C Lee; Faye L Wong; Patricia M Jamison; Sandra F Jones; Louise Galaska; Kevin T Brady; Barbara Wethers; George-Ann Stokes-Townsend Journal: Cancer Date: 2014-08-15 Impact factor: 6.860
Authors: Vicki B Benard; Christie R Eheman; Herschel W Lawson; Donald K Blackman; Christa Anderson; William Helsel; Sandra F Thames; Nancy C Lee Journal: Obstet Gynecol Date: 2004-03 Impact factor: 7.661
Authors: Alan G Waxman; Lee E Buenconsejo-Lum; Miriam Cremer; Sarah Feldman; Kevin A Ault; Joanna M Cain; Maria Lina Diaz Journal: J Low Genit Tract Dis Date: 2016-01 Impact factor: 1.925
Authors: Julie S Townsend; Analía Romina Stormo; Katherine B Roland; Lee Buenconsejo-Lum; Susan White; Mona Saraiya Journal: Oncologist Date: 2014-03-25
Authors: Vicki B Benard; Cheryll C Thomas; Jessica King; Greta M Massetti; V Paul Doria-Rose; Mona Saraiya Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-07 Impact factor: 17.586